Related Experiment Video

Updated: Aug 16, 2026

Nanoparticle Delivery of an Oligonucleotide Payload in a Glioblastoma Multiforme Animal Model
09:02

Nanoparticle Delivery of an Oligonucleotide Payload in a Glioblastoma Multiforme Animal Model

Published on: September 27, 2024

Novel advances in drug delivery to brain cancer

Maciej S Lesniak1

  • 1Division of Neurosurgery, The University of Chicago Pritzker School of Medicine, 5841 South Maryland Avenue, Chicago, Illinois 60637, USA. mlesniak@surgery.bsd.uchicago.edu

Technology in Cancer Research & Treatment
|July 21, 2005
PubMed

Insights

Local drug delivery using biodegradable polymers improves brain tumor therapy by directly targeting tumors, enhancing patient survival. This approach expands treatment options for malignant brain tumors.

Area of Science:

  • Oncology
  • Biomaterials Science
  • Neuroscience

Background:

  • Brain tumor therapy is challenged by limited drug delivery across the blood-brain barrier.
  • Systemic drug administration often causes toxic side effects and insufficient tumor concentrations.
  • Local and controlled drug delivery offers a promising strategy to overcome these limitations.

Purpose of the Study:

  • To review the rationale behind local drug delivery for brain tumors.
  • To discuss the development of polymer-based therapeutic agents for brain tumor treatment.
  • To highlight novel non-polymer drug delivery methods for malignant brain tumors.

Main Methods:

  • Review of existing literature on polymer-based drug delivery systems for brain tumors.
  • Analysis of therapeutic strategies utilizing biodegradable polymers for localized chemotherapy.
  • Exploration of emerging non-polymer drug delivery technologies.

Main Results:

  • Biodegradable polymers enable prolonged, localized exposure of tumor cells to chemotherapeutic agents.
  • This localized delivery strategy has demonstrated improved survival rates in patients with malignant brain tumors.
  • The use of polymers broadens the range of drugs applicable to brain tumor treatment.

Conclusions:

  • Local and controlled drug delivery, particularly using biodegradable polymers, is a vital advancement in brain tumor therapy.
  • Polymer-based systems offer a safe and effective means to achieve therapeutic drug concentrations within brain tumors.
  • Further research into both polymer and non-polymer drug delivery methods holds significant promise for improving outcomes in malignant brain tumor treatment.

More Related Videos

Mouse Microsurgery Infusion Technique for Targeted Substance Delivery into the CNS via the Internal Carotid Artery06:41

Mouse Microsurgery Infusion Technique for Targeted Substance Delivery into the CNS via the Internal Carotid Artery

Published on: January 31, 2017

Delivery of Antibodies into the Murine Brain via Convection-enhanced Delivery08:22

Delivery of Antibodies into the Murine Brain via Convection-enhanced Delivery

Published on: July 18, 2019

Related Concept Videos

Drug Delivery: Parenteral Route01:29

Drug Delivery: Parenteral Route

The parenteral route is a critical method of drug administration. It delivers compounds directly into the systemic circulation and bypasses the gastrointestinal tract. This approach is particularly advantageous for drugs that exhibit poor absorption or instability when administered orally.
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
Drug Delivery: Overview01:16

Drug Delivery: Overview

The selection of a drug's delivery route depends upon its physicochemical properties, including lipid or water solubility and ionization, as well as the therapeutic requirement, such as immediate or sustained effect. These routes can be divided into three primary categories: enteral, parenteral, and topical.
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the gastrointestinal...
Modified-Release Drug Delivery Systems: Site-Targeted01:24

Modified-Release Drug Delivery Systems: Site-Targeted

Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
Drug Delivery: Miscellaneous Routes01:22

Drug Delivery: Miscellaneous Routes

Drug delivery methods like oral inhalation, nasal sprays, transdermal patches, eye drops, intravitreal injection,  and rectal administration provide localized effects with reduced toxicity.
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs through the...
Site-Targeted Drug Delivery Systems: Polymeric Carriers01:24

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
Drug Delivery Systems: Different Types01:27

Drug Delivery Systems: Different Types

Conventional oral drug products, termed immediate-release (IR) formulations, are engineered to promptly release their active pharmaceutical ingredient (API) upon ingestion, typically in tablets or capsules. This rapid release often results in swift drug absorption and consequent pharmacodynamic effects, although the timing and intensity can vary depending on the drug's properties. Prodrugs within these formulations require metabolic conversion to activate their pharmacodynamic effects,...